Common use of Overallotment Clause in Contracts

Overallotment. In the event any Purchaser fails to exercise its right to purchase its pro rata share of New Securities, each Purchaser who delivered an Exercise Notice for such Purchaser’s total pro rata share of New Securities (an “Overallotment Purchaser”) shall have a right to purchase such Overallotment Purchaser’s pro rata share of the New Securities with respect to which Purchasers have failed to exercise their rights hereunder (“Remaining New Securities”). In such case, within twenty-five (25) days after the delivery of the Sale Notice, the Company shall provide written notice (“Overallotment Notice”) to each Overallotment Purchaser, which shall state the total amount of Remaining New Securities, and the pro rata portion of such Remaining New Securities which each Overallotment Purchaser is entitled to purchase. Each Overallotment Purchaser wishing to purchase any Remaining New Securities shall amend such Overallotment Purchaser’s Exercise Notice in writing within five (5) days from the date of delivery of the Overallotment Notice. For the purpose of this Section 2.4, an Overallotment Purchaser’s pro rata share of the Remaining New Securities shall be calculated as provided in Section 2.2, except that the denominator of the fraction shall be the total number of shares of Common Stock issued or issuable upon conversion of shares of Preferred Stock held by all of the Overallotment Purchasers.

Appears in 3 contracts

Samples: Investors’ Rights Agreement (BIND Therapeutics, Inc), Investors’ Rights Agreement (BIND Therapeutics, Inc), Investors’ Rights Agreement (Rusnano)

AutoNDA by SimpleDocs

Overallotment. In the event any Purchaser fails to exercise its right to purchase its pro rata share of New Securities, each Purchaser who delivered an Exercise Notice for such Purchaser’s total pro rata share of New Securities (an “Overallotment Purchaser”) shall have a right to purchase such Overallotment Purchaser’s pro rata share of the New Securities with respect to which Purchasers have failed to exercise their rights hereunder (“Remaining New Securities”). In such case, within twenty-twenty five (25) days after the delivery of the Sale Notice, the Company shall provide written notice (“Overallotment Notice”) to each Overallotment Purchaser, which shall state the total amount of Remaining New Securities, and the pro rata portion of such Remaining New Securities which each Overallotment Purchaser is entitled to purchase. Each Overallotment Purchaser wishing to purchase any Remaining New Securities shall amend such Overallotment Purchaser’s Exercise Notice in writing within five (5) days from the date of delivery of the Overallotment Notice. For the purpose of this Section 2.4, an Overallotment Purchaser’s pro rata share of the Remaining New Securities shall be calculated as provided in Section 2.2, except that the denominator of the fraction shall be the total number of shares of Common Stock issued or issuable upon conversion of shares of Senior Preferred Stock held by all of the Overallotment Purchasers.

Appears in 3 contracts

Samples: Investors’ Rights Agreement (Selecta Biosciences Inc), Investors’ Rights Agreement (Selecta Biosciences Inc), Investors’ Rights Agreement (Selecta Biosciences Inc)

Overallotment. In the event any Purchaser Preferred Investor fails to exercise its right to purchase its pro rata share Pro Rata Share of New Securities, each Purchaser Preferred Investor who delivered an Exercise Notice for such PurchaserPreferred Investor’s total pro rata share Pro Rata Share of New Securities (an “Overallotment PurchaserPreferred Investor”) shall have a right to purchase such Overallotment PurchaserPreferred Investor’s pro rata share of the New Securities with respect to which Purchasers Preferred Investors have failed to exercise their rights hereunder (“Remaining New Securities”). In such case, within twenty-twenty five (25) days after the delivery date of the Sale Notice, the Company shall provide written notice (“Overallotment Notice”) to each Overallotment PurchaserPreferred Investor, which shall state the total amount of Remaining New Securities, and the pro rata portion of such Remaining New Securities which each Overallotment Purchaser Preferred Investor is entitled to purchase. Each Overallotment Purchaser Preferred Investor wishing to purchase any such Remaining New Securities shall amend such Overallotment PurchaserPreferred Investor’s Exercise Notice in writing within five ten (510) days from the date of delivery of the Overallotment Notice. For the purpose of this Section 2.47.4, an Overallotment PurchaserPreferred Investor’s pro rata share of the Remaining New Securities shall be calculated as provided in Section 2.27.2, except that the denominator of the fraction shall be the total number of shares of Common Stock issued or issuable upon conversion of shares of Preferred Stock held by all of the Overallotment PurchasersPreferred Investors but shall exclude shares of Common Stock issuable on conversion of other preferred stock or other convertible securities or on exercise of options, rights, or warrants.

Appears in 2 contracts

Samples: Purchase Agreement (Cerulean Pharma Inc.), Purchase Agreement (Cerulean Pharma Inc.)

AutoNDA by SimpleDocs

Overallotment. In the event any Purchaser fails to exercise its right to purchase its pro rata share of New SecuritiesSecurities calculated in accordance with Section 2.2, each Purchaser who delivered an Exercise Notice for such Purchaser’s total pro rata share of New Securities (an “Overallotment Purchaser”) shall have a right to purchase such Overallotment Purchaser’s pro rata share of the New Securities with respect to which Purchasers have failed to exercise their rights hereunder (“Remaining New Securities”). In such case, within twenty-five (25) days after the delivery of the Sale Notice, the Company shall provide written notice (“Overallotment Notice”) to each Overallotment Purchaser, which shall state the total amount of Remaining New Securities, and the pro rata portion of such Remaining New Securities which each Overallotment Purchaser is entitled to purchase. Each Overallotment Purchaser wishing to purchase any such Remaining New Securities shall amend such Overallotment Purchaser’s Exercise Notice in writing within five (5) days from the date of delivery of the Overallotment Notice. For the purpose of this Section 2.4, an Overallotment Purchaser’s pro rata share of the Remaining New Securities shall be calculated as provided in Section 2.2, except that the denominator of the fraction shall be the total number of shares of Common Stock issued or issuable upon conversion of shares of Preferred Stock held by all of the Overallotment Purchasers.

Appears in 1 contract

Samples: Investors’ Rights Agreement (Organovo Holdings, Inc.)

Time is Money Join Law Insider Premium to draft better contracts faster.